Why is $EVMN moving today? · SEC 8-K archive

$EVMN SEC Filing Alert & Real-Time AI Stock Impact Analysis

T0 SEO archive for $EVMN: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).

← All archive signals

FAQ: $EVMN filing catalyst

Why did $EVMN trigger an AI stock catalyst alert?

$EVMN triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: +3.0/10). Headline: Evommune In-Licenses EVO570 from Hinova for $30M Upfront and up to $1.1B in Milestones. Key points: - Exclusive license agreement to develop and commercialize oral VAV1 degrader EVO570. - Consideration includes $20M cash upfront, $10M in pre-funded warrants, and up to $1.1B in milestones. - Phase 1 initiation imminent; Phase 2 trial in rheumatoid arthritis planned for 2027.

How did $EVMN stock react after the SEC filing?

After the SEC 8-K for $EVMN, observed market reaction: T0 price $6.04. Past moves do not guarantee future results.

Where can I get real-time $EVMN SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $EVMN via Telegram and the VIP Web Terminal from €10/month.

$EVMN

$EVMN – Evommune In-Licenses EVO570 from Hinova for $30M Upfront and up to $1.1B in Milestones

Evommune, Inc.

2026-11-04 00:00:00 UTC · SEC 8-K · All $EVMN

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+3.0 / 10)

Exclusive license agreement to develop and commercialize oral VAV1 degrader EVO570.
Consideration includes $20M cash upfront, $10M in pre-funded warrants, and up to $1.1B in milestones.
Phase 1 initiation imminent; Phase 2 trial in rheumatoid arthritis planned for 2027.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →